Intuitive Surgical Shares Decline 13%

Intuitive Surgical’s stock fell as much as 13% in the final trading hours, reflecting investor concerns after the company’s latest quarterly report showed growth in usage of its da Vinci surgical robots slide to the lowest level in four years. The slowdown in the growth rate of robotic surgery, particularly the slower‑than‑expected rise in procedure volumes, has heightened uncertainty among market participants, especially since Intuitive Surgical has not revised its 2024 procedure‑growth targets. Analysts have questioned the sustainability of the company’s long‑term growth strategy. In particular, intensifying competition for robotic surgical equipment and mounting cost pressures could erode profitability. Market participants sold shares of Intuitive Surgical, adopting a cautious stance on the company’s future growth potential and competitive advantages. This development may prompt investors to reassess their risk tolerance. This is not investment advice.